PuraPharm Corporation Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	163	190	217	356	506	319
Market Cap Growth	-26.23%	-12.58%	-38.89%	-29.69%	58.47%	19.41%
Enterprise Value	498	515	579	734	886	732
Last Close Price	0.30	0.35	0.55	0.90	1.28	0.81
Forward PE	-	13.33	13.33	13.33	13.33	13.33
PS Ratio	0.49	0.56	0.57	0.87	1.13	0.48
PB Ratio	1.25	1.46	1.95	2.32	1.96	0.80
P/TBV Ratio	3.58	4.17	3.52	3.54	2.53	0.94
P/FCF Ratio	-	-	2.44	5.88	7.47	-
P/OCF Ratio	-	-	2.09	4.47	5.71	-
EV/Sales Ratio	1.48	1.53	1.52	1.80	1.98	1.11
EV/EBITDA Ratio	28.99	29.79	39.56	-	-	18.24
EV/EBIT Ratio	-	-	-	-	-	48.34
EV/FCF Ratio	-	-	6.49	12.14	13.10	-
Debt / Equity Ratio	2.69	2.69	3.27	2.77	1.95	1.33
Debt / EBITDA Ratio	20.33	20.33	10.82	-	-	8.53
Debt / FCF Ratio	-	-	4.08	7.03	7.44	-
Net Debt / Equity Ratio	2.57	2.57	2.94	2.49	1.59	1.09
Net Debt / EBITDA Ratio	19.39	19.39	22.34	-13.10	-9.78	10.87
Net Debt / FCF Ratio	-	-	3.67	6.32	6.09	-24.75
Asset Turnover	0.48	0.48	0.49	0.44	0.40	0.51
Inventory Turnover	1.40	1.40	1.18	1.04	0.95	1.21
Quick Ratio	0.15	0.15	0.20	0.23	0.35	0.54
Current Ratio	0.47	0.47	0.55	0.61	0.73	0.92
Return on Equity (ROE)	-29.15%	-29.15%	-26.80%	-51.55%	-36.44%	-26.69%
Return on Assets (ROA)	-1.44%	-1.44%	-1.51%	-3.57%	-3.84%	0.73%
Return on Invested Capital (ROIC)	-3.48%	-3.59%	-3.88%	-8.83%	-9.05%	1.74%
Return on Capital Employed (ROCE)	-7.60%	-7.60%	-8.40%	-19.50%	-19.40%	2.80%
Earnings Yield	-21.58%	-18.54%	-16.31%	-29.84%	-23.77%	-38.20%
FCF Yield	-	-	41.04%	16.99%	13.38%	-5.52%
Buyback Yield / Dilution	-6.00%	-6.00%	-	-0.12%	-0.22%	-6.01%
Total Shareholder Return	-6.00%	-6.00%	-	-0.12%	-0.22%	-6.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.